Aandelen in “Productie van biologische producten”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Cardiff Oncology Inc |
22/11 | 2,450 USD
-2,00% |
-2,00% |
|
CASI Pharmaceuticals Inc |
22/11 | 5,100 USD
-2,86% |
-2,86% |
|
Cel-Sci Corp. |
22/11 | 0,596 USD
-1,44% |
-1,44% |
|
Celldex Therapeutics Inc. |
22/11 | 27,020 USD
+3,05% |
+3,05% |
Cellectis |
22/11 | 1,726 EUR
+0,94% |
+0,94% |
|
Cellectis |
22/11 | 1,870 USD
+0,54% |
+0,54% |
|
Champions Oncology Inc |
22/11 | 4,550 USD
+6,56% |
+6,56% |
|
Cidara Therapeutics Inc |
22/11 | 20,400 USD
+16,91% |
+16,91% |
|
Coherus Biosciences Inc |
22/11 | 1,090 USD
-0,91% |
-0,91% |
|
CRISPR Therapeutics AG |
22/11 | 47,880 USD
+3,43% |
+3,43% |
|
Curis Inc |
22/11 | 4,030 USD
-1,71% |
-1,71% |
Nieuws over “Productie van biologische producten”
